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206been described only in the right precordial leads and
within the QRS complex in BS, indicating a regional
conduction disturbance in the right ventricular
outﬂow tract in these patients (2). ER may appear as
a notching of the terminal QRS in the inferolateral
leads and is an increasingly recognized risk factor
for ventricular ﬁbrillation and electrical storm in pa-
tients with BS (3,4). As in this patient, the ER pattern
is decreased by sodium channel blockers in sole ER
and in patients with BS and additional inferolateral
ER (5). The contrary responses to sodium channel
blockers in BS (accentuation of ST elevation) and in
ER (attenuation of ER pattern) may point to different
underlying mechanisms for both diseases. It would be
interesting to know whether this BS patient with
additional inferolateral ER and history of electrical
storm is 1 of the 2 patients that have successfully been
treated with quinidine, as this drug is highly effective
in both diseases, BS and ER syndrome.*Johannes Steinfurt, MD
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Apart from the coved-type ST-segment elevation
in the right precordial leads, the heterogeneity ofBrugada syndrome (BS) can lead to additional elec-
trocardiographic (ECG) repolarization abnormalities
and even to abnormal depolarization features (2,3).
Moreover, both abnormalities might coexist on the
ECG of the same patient, and the combination of such
ﬁndings seems to confer even a higher risk for further
arrhythmic events (4).
Early repolarization (ER) may present either as
QRS slurring (a smooth transition from the QRS
segment to the ST-segment) or notching (a positive J
deﬂection of at least 1 mm inscribed on the S-wave)
in the inferior leads (II, III, and aVF), lateral leads (I,
aVL, and V4 to V6), or both. Ajmaline challenge can
normalize an inferolateral J wave and increase S-
wave amplitude in patients with an ER pattern or BS
(5). In addition, a drug challenge can unmask the
diagnostic Brugada ECG pattern exclusively in the
inferior–lateral leads more frequently in patients
with BS with a baseline ER pattern (2).
In this patient with BS who experienced an elec-
trical storm, the baseline ECG was considered to
have a depolarization abnormality rather than repo-
larization abnormalities (1). A notching in the ter-
minal part of the QRS complex without ST-segment
elevation was present not only in the inferolateral
leads, but was also diffuse in all leads. Furthermore,
a slurring of QRS with fragmentation of the terminal
part was present even in leads aVR and V1, and there
was no J deﬂection inscribed on the S wave that was
positive in all leads. Finally, ajmaline unmasked a
type I ECG in leads V1 and V2 and did not provoke
the diagnostic pattern in the inferolateral leads. The
signiﬁcance of the presence of a global conduction
slowing in patients with BS who present with diffuse
fragmentation of QRS on a baseline 12-lead ECG has
not been fully understood and should merit further
investigation.*Giulio Conte, MD, PhD
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Patients Undergoing
Transcatheter Aortic
Valve ReplacementIn the PARTNER (Placement of Aortic Transcatheter
Valve Trial) study, similar to other studies, mild,
moderate, or severe aortic regurgitation (AR) after
transcatheter aortic valve replacement (TAVR) was
associated with 1-year, all-cause mortality (1). In
the February 10, 2015, issue of the Journal, Urena
et al. (2) studied late cardiac death in a prospective
cohort of 3,726 TAVR patients. After a follow-up of
22  18 months, moderate or severe AR, using
VARC (Valve Academic Research Consortium)-2
criteria, occurred in 11% of patients and indepen-
dently predicted death due to advanced heart fail-
ure (HF). Although several mechanisms linking AR
and death post-TAVR have been proposed (3),
including bias due to confounding factors (AR as a
marker), this study by Urena et al. (2) tends
to suggest that AR is deleterious in itself (AR as the
cause), and could potentially lead to progression to
advanced HF.
We want to congratulate the investigators for
shedding light on an important issue and to shareour complementary ﬁndings. In our recent work,
the recovery of left ventricular (LV) myocardial
mechanics was analyzed at mid-term follow-up (5 
3 months) after TAVR in a cohort of 64 patients
(the transapical approach was used in 61%) using
speckle-tracking echocardiography (4). The pres-
ence of new mild AR and any moderate or severe
AR was associated with an increase in LV diastolic
and systolic volumes, lack of LV mass regression,
and the lack of improvement in global longitudinal
LV systolic strain, strain rate, and early dias-
tolic strain rate post-TAVR, as opposed to patients
without AR.
Therefore, not only does post-TAVR AR acutely
reduce forward stroke volume and increase LV end-
diastolic pressure, it also importantly prevents LV
structural and functional recovery at mid-term
follow-up. Pathophysiologically, the sudden change
from pressure overload to volume overload in a
concentric hypertrophied LV appears to blunt the
favorable LV remodeling that is expected to occur
following the resolution of chronic pressure overload
by TAVR. These observations elucidate the plausible
causal mechanisms linking post-TAVR AR to HF
events and support the intrinsic impact of post-
TAVR AR in modulating prognosis, as shown by
Urena et al. (2).*Frédéric Poulin, MD, MSc
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